Skip to Content

Therapeutic Strategies During Cenobamate Treatment Initiation

This MEDtalk highlights Dr. Elinor Ben-Menachem’s expertise in epilepsy research, focusing on the newly approved anti-seizure medication cenobamate. With its dual mechanism of action, cenobamate shows potential as a highly effective treatment for focal-onset seizures, offering new hope for patients when carefully managed with existing therapies.

Elinor Ben-menachem

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top